Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.5959
0.058.23%
At close: -
$0.5999
0.004000.67%
After Hours: 7:47 PM EDT
Comments
Loading...
Unicycive Therapeutics Stock Price, Quotes and Forecasts
UNCYNASDAQ
Unicycive Therapeutics (UNCY) Forecast
NewsEarningsUnicycive Therapeutics (UNCY) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Unicycive Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:UNCY | Benzinga
Explore Unicycive Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for UNCY.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Unicycive Therapeutics (UNCY) stock?
You can purchase shares of Unicycive Therapeutics (NASDAQ:UNCY) through any online brokerage.
Who are Unicycive Therapeutics (UNCY) competitors?
Other companies in Unicycive Therapeutics’s space includes: Kalaris Therapeutics (NASDAQ:KLRS), Skye Bioscience (NASDAQ:SKYE), Inovio Pharmaceuticals (NASDAQ:INO), Citius Oncology (NASDAQ:CTOR) and Adaptimmune Therapeutics (NASDAQ:ADAP).
What is the forecast, or price target, for Unicycive Therapeutics (UNCY) stock?
Unicycive Therapeutics has a consensus price target of $6.07.
What is the current price for Unicycive Therapeutics (UNCY)?
The stock price for Unicycive Therapeutics (NASDAQ: UNCY) is $0.5999 last updated May 16, 2025 at 7:47 PM EDT.
Does Unicycive Therapeutics (UNCY) pay a dividend?
There are no upcoming dividends for Unicycive Therapeutics.
When is Unicycive Therapeutics (NASDAQ:UNCY) reporting earnings?
Unicycive Therapeutics’s Q2 earnings are confirmed for Wednesday, August 13, 2025.
Is Unicycive Therapeutics (UNCY) going to split?
There is no upcoming split for Unicycive Therapeutics.
What sector and industry does Unicycive Therapeutics (UNCY) operate in?
Unicycive Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
